Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE IOBBI-NIVOL : revenue, balance sheet and financial ratios

PHARMACIE IOBBI-NIVOL is a French company founded 38 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in LES ABRETS-EN-DAUPHINE (38490), this company of category PME shows in 2023 a revenue of 2.0 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Historique financier - PHARMACIE IOBBI-NIVOL (SIREN 341490233)
Kennzahl 2025 2024 2023 2022 2021 2020 2019 2018
Umsatz N/C N/C 1 968 289 € N/C N/C N/C N/C N/C
Nettoergebnis 41 248 € 28 817 € 101 903 € 118 936 € 79 785 € 118 981 € 104 950 € 68 702 €
EBITDA N/C N/C 145 945 € N/C N/C N/C N/C N/C
Nettomarge N/C N/C 5.2% N/C N/C N/C N/C N/C

Umsatz und Gewinn- und Verlustrechnung

In 2025, PHARMACIE IOBBI-NIVOL generates positive net income of 41 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2025: 69 k€ -> 41 k€.

Nettoergebnis (2025) ?
Nettoergebnis
Definition
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Formel
Ordentliches Ergebnis + Außerordentliches Ergebnis - Ertragsteuern

41 248 €

Chargement du compte de résultat...

Évolution graphique

Anzeigen :

Aktiva

Chargement des données...

Passiva

Chargement des données...

Solvenz- und Verschuldungskennzahlen

The debt ratio (= Financial debt / Equity x 100) stands at 149%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 31%. The balance between equity and debt is satisfactory.

Verschuldungsgrad (2025) ?
Verschuldungsgrad
Definition
Misst das Verhältnis von Schulden zu Eigenkapital.
Formel
(Finanzschulden / Eigenkapital) x 100
Interpretation
< 50% : Faible
50-100% : Moderat
> 100% : Hoch

148.67%

Finanzielle Autonomie (2025) ?
Finanzielle Autonomie
Definition
Anteil des Eigenkapitals an der Gesamtfinanzierung.
Formel
(Eigenkapital / Bilanzsumme) x 100
Interpretation
> 30% : Gute Autonomie
20-30% : Durchschnitt
< 20% : Faible

31.107%

Anlagenaltersquote (2025) ?
Anlagenaltersquote
Definition
Misst den Abnutzungsgrad des Sachanlagevermögens.
Formel
Kumulierte Abschreibungen / Bruttoanlagevermögen x 100
Interpretation
< 50% : Neue Anlagen
50-70% : Normale Abnutzung
> 70% : Alternde Anlagen

20.7%

Entwicklung der Solvenzkennzahlen
PHARMACIE IOBBI-NIVOL

Positionnement sectoriel

Debt ratio
148.67 2025
2023
2024
2025
Q1: 13.57
Méd: 49.47
Q3: 128.28
Average

In 2025, the debt ratio of PHARMACIE IOBBI-NIVOL (148.67) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
31.11% 2025
2023
2024
2025
Q1: 33.69%
Méd: 53.88%
Q3: 72.26%
Average

In 2025, the financial autonomy of PHARMACIE IOBBI-NIVOL (31.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
7.73 years 2023
2023
Q1: 0.95 years
Méd: 3.58 years
Q3: 7.48 years
Average

In 2023, the repayment capacity of PHARMACIE IOBBI-NIVOL (7.73) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquiditätskennzahlen

The liquidity ratio (= Current assets / Current liabilities) stands at 112.30. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquiditätsquote (2025) ?
Liquiditätsquote
Definition
Fähigkeit, kurzfristige Schulden mit dem Umlaufvermögen zu decken.
Formel
Umlaufvermögen / Kurzfristige Verbindlichkeiten
Interpretation
> 1.5 : Sehr gut
1-1.5 : Angemessen
< 1 : Risque de liquidité

112.299

Entwicklung der Liquiditätskennzahlen
PHARMACIE IOBBI-NIVOL

Positionnement sectoriel

Liquidity ratio
112.3 2025
2023
2024
2025
Q1: 131.48
Méd: 182.6
Q3: 258.72
Watch -30 pts über 3 Jahre

In 2025, the liquidity ratio of PHARMACIE IOBBI-NIVOL (112.30) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Interest coverage
4.57x 2023
2023
Q1: 0.38x
Méd: 2.71x
Q3: 6.47x
Good

In 2023, the interest coverage of PHARMACIE IOBBI-NIVOL (4.6x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Umlaufvermögensbedarf und Zahlungsfristen

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operatives Working Capital (2025) ?
Operatives Working Capital
Definition
Besoin de financement généré par le cycle d'exploitation (stocks + créances - dettes fournisseurs).
Formel
Stocks + Créances clients - Dettes fournisseurs
Interpretation
Negativ = freigesetzte Liquidität
Positiv = Finanzierungsbedarf

0 €

Kundenforderungen (2025) ?
Kundenforderungen (Tage)
Definition
Durchschnittliche Zahlungsfrist für Kunden.
Formel
(Kundenforderungen / Umsatz inkl. MwSt.) x 360
Interpretation
< 45j : Gut
45-60j : Durchschnitt
> 60j : Lang

0 j

Lieferantenverbindlichkeiten (2025) ?
Lieferantenverbindlichkeiten (Tage)
Definition
Durchschnittliche Zahlungsfrist von Lieferanten.
Formel
(Lieferantenverbindlichkeiten / Einkäufe inkl. MwSt.) x 360
Interpretation
Je länger die Frist, desto besser für die Liquidität

0 j

Lagerumschlag (2025) ?
Lagerumschlag (Tage)
Definition
Durchschnittliche Lagerdauer für Waren oder Materialien.
Formel
(Vorräte / Einkaufskosten) x 360
Interpretation
Je niedriger das Verhältnis, desto schneller der Umschlag

0 j

Entwicklung des Working Capital und der Zahlungsfristen
PHARMACIE IOBBI-NIVOL

Positionnement de PHARMACIE IOBBI-NIVOL dans son secteur

Vergleich mit der Branche Commerce de détail de produits pharmaceutiques en magasin spécialisé

Bewertungsschätzung

Based on 277 transactions of similar company sales in 2025, the value of PHARMACIE IOBBI-NIVOL is estimated at 655 229 € (range 444 641€ - 1 028 145€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
444k€ 655k€ 1028k€
655 229 € Range: 444 641€ - 1 028 145€
NAF 5 année 2025

Valuation method used

Net Income Multiple
41 248 € × 15.9x = 655 229 €
Range: 444 642€ - 1 028 145€

Only this financial indicator is available for this company.

Bewertungsentwicklung

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE IOBBI-NIVOL with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE IOBBI-NIVOL

What is the revenue of PHARMACIE IOBBI-NIVOL ?

The revenue of PHARMACIE IOBBI-NIVOL in 2023 is 2.0 M€.

Is PHARMACIE IOBBI-NIVOL profitable?

Yes, PHARMACIE IOBBI-NIVOL generated a net profit of 41 k€ in 2025.

Where is the headquarters of PHARMACIE IOBBI-NIVOL ?

The headquarters of PHARMACIE IOBBI-NIVOL is located in LES ABRETS-EN-DAUPHINE (38490), in the department Isere.

Where to find the tax return of PHARMACIE IOBBI-NIVOL ?

The tax return of PHARMACIE IOBBI-NIVOL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE IOBBI-NIVOL operate?

PHARMACIE IOBBI-NIVOL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.